ERBB2 and breast cancer: Clinically, the molecular subtypes of BC are luminal A (LumA), luminal B (LumB), triple-negative breast cancer (TNBC), and HER2-positive BC, and each has distinct therapeutic approaches and efficacies [21, 23, 25–27].